Paul Tudor Jones Rhythm Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 4,272 shares of RYTM stock, worth $461,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,272

Previous 29,513 85.53%

Holding current value

$461,418

Previous $1.56 Million 82.79%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$46.95 - $68.11 $1.19 Million - $1.72 Million	-25,241 Reduced 85.53%	4,272 $269,000
Q1 2025 May 15, 2025	BUY	$48.56 - $61.02 $692,854 - $870,633	14,268 Added 93.59%	29,513 $1.56 Million
Q4 2024 Feb 14, 2025	BUY	$46.91 - $67.33 $715,142 - $1.03 Million	15,245 New	15,245 $852,000
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $330,759 - $443,380	8,455 Added 172.55%	13,355 $578,000
Q4 2023 Feb 14, 2024	SELL	$21.39 - $49.64 $522,857 - $1.21 Million	-24,444 Reduced 83.3%	4,900 $225,000
Q3 2023 Nov 15, 2023	BUY	$15.81 - $27.8 $283,805 - $499,037	17,951 Added 157.56%	29,344 $672,000
Q2 2023 Aug 14, 2023	SELL	$16.32 - $21.15 $236,329 - $306,273	-14,481 Reduced 55.97%	11,393 $187,000
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $436,753 - $885,925	25,874 New	25,874 $462,000
Q3 2022 Nov 14, 2022	SELL	$4.3 - $30.85 $178,966 - $1.28 Million	-41,620 Reduced 33.19%	83,796 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $231,435 - $908,680	74,178 Added 144.77%	125,416 $520,000
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $133,388 - $266,342	21,760 Added 73.82%	51,238 $590,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $254,100 - $409,744	29,478 New	29,478 $294,000
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $1.24 Million - $1.51 Million	-66,852 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $1.35 Million - $2.64 Million	66,852 New	66,852 $1.42 Million
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $209,388 - $278,124	-7,758 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $132,041 - $273,081	7,758 New	7,758 $243,000

Others Institutions Holding RYTM

# of Institutions

249

Shares Held

63.9M

Call Options Held

210K

Put Options Held

575K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $6.02B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account